SANGAMO THERAPEUTICS, INC. Shareholders' Equity
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Shareholders' Equity of -$18.95 million as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-05-14
- 2026-03-31: Stockholders' Equity Attributable to Parent -$18.95M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$14.27M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $6.24M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $19.60M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-03-31 | -$18.95M 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$14.27M 10-Q · filed 2026-05-14 |
| 2025-09-30 | $6.24M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $19.60M 10-Q · filed 2025-11-06 |
| 2025-03-31 | $4.91M 10-Q · filed 2026-05-14 |
| 2024-12-31 | $22.77M 10-Q · filed 2026-05-14 |
| 2024-09-30 | $39.13M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $23.69M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $56.70M 10-Q · filed 2025-08-07 |
| 2023-12-31 | $82.89M 10-K · filed 2026-03-30 |
| 2023-09-30 | $134.92M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $233.64M 10-Q · filed 2024-11-12 |
| 2023-03-31 | $335.61M 10-Q · filed 2024-08-06 |
| 2022-12-31 | $294.96M 10-K · filed 2025-03-17 |
| 2022-09-30 | $309.15M 10-Q · filed 2023-11-01 |
| 2022-06-30 | $318.28M 10-Q · filed 2023-11-01 |
| 2022-03-31 | $334.52M 10-Q · filed 2023-08-08 |
| 2021-12-31 | $375.34M 10-Q · filed 2023-11-01 |
| 2021-09-30 | $406.02M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $445.46M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $470.36M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $498.23M 10-K · filed 2022-02-24 |
| 2020-09-30 | $521.41M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $511.46M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $394.29M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $432.55M 10-K · filed 2021-02-24 |
| 2019-09-30 | $419.09M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $445.13M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $328.50M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $366.52M 10-K · filed 2020-02-28 |
| 2018-09-30 | $379.91M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $387.87M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $182.37M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $187.90M 10-K · filed 2019-03-01 |
| 2017-09-30 | $186.65M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $194.04M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $125.68M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $136.19M 10-K · filed 2018-03-01 |
| 2016-09-30 | $143.84M 10-Q · filed 2016-10-27 |
| 2016-06-30 | $160.02M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $179.41M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $192.44M 10-K · filed 2018-03-01 |
| 2015-09-30 | $203.56M 10-Q · filed 2015-10-30 |
| 2015-06-30 | $199.94M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $207.49M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $206.63M 10-K · filed 2018-03-01 |
| 2014-09-30 | $210.14M 10-Q · filed 2014-10-28 |
| 2014-06-30 | $214.36M 10-Q · filed 2014-07-29 |
| 2014-03-31 | $217.43M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $121.71M 10-K · filed 2017-02-28 |
| 2013-09-30 | $126.14M 10-Q · filed 2013-11-04 |
| 2013-06-30 | $59.38M 10-Q · filed 2013-08-02 |
| 2013-03-31 | $61.59M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $64.90M 10-K · filed 2016-02-18 |
| 2012-09-30 | $66.40M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $70.23M 10-Q · filed 2012-08-03 |
| 2012-03-31 | $74.34M 10-Q · filed 2012-05-07 |
| 2011-12-31 | $80.13M 10-K · filed 2015-02-25 |
| 2011-09-30 | $84.17M 10-Q · filed 2011-11-04 |
| 2011-06-30 | $91.61M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $55.91M 10-K · filed 2014-02-24 |
| 2009-12-31 | $71.78M 10-K · filed 2013-02-26 |
| 2008-12-31 | $55.40M 10-K · filed 2012-02-23 |